---
title: "Smith+Nephew CEO Deepak Nath to Join Reckitt Board as Independent Director"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277958369.md"
description: "Smith+Nephew CEO Deepak Nath will join Reckitt Benckiser Group's board as an independent director starting April 1, 2026. This appointment, announced on March 5, 2026, aligns with UK listing rules and enhances Nath's governance profile while he continues leading Smith+Nephew. Analysts rate Smith+Nephew stock (SNN) as a Buy with a $41.00 price target, citing improving financial performance and positive momentum, despite some near-term challenges. Smith+Nephew, a global medtech company, generated $6.2 billion in sales in 2025 and has a market cap of $15.17 billion."
datetime: "2026-03-05T14:56:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277958369.md)
  - [en](https://longbridge.com/en/news/277958369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277958369.md)
---

# Smith+Nephew CEO Deepak Nath to Join Reckitt Board as Independent Director

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Smith & Nephew Snats ( (SNN) ) has issued an update.

Smith+Nephew has disclosed that its Chief Executive Officer, Deepak Nath, will join the board of consumer health and hygiene group Reckitt Benckiser Group as an independent non-executive director from 1 April 2026. The appointment, announced on 5 March 2026 in line with UK listing rules, adds an additional high-profile external governance role for Nath, potentially broadening his strategic exposure and networks while he continues to lead the FTSE 100 medtech group.

The most recent analyst rating on (SNN) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.

**Spark’s Take on SNN Stock**

According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.

The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.

To see Spark’s full report on SNN stock, click here.

**More about Smith & Nephew Snats**

Smith+Nephew is a global medical technology company focused on the repair, regeneration and replacement of soft and hard tissue, operating through Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, it now employs about 17,000 people, operates in more than 100 countries, generated $6.2 billion in sales in 2025, and is listed on both the London Stock Exchange and the New York Stock Exchange as a FTSE 100 constituent.

**Average Trading Volume:** 835,699

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $15.17B

For an in-depth examination of SNN stock, go to TipRanks’ Overview page.

### Related Stocks

- [SNN.US](https://longbridge.com/en/quote/SNN.US.md)
- [RBGLY.US](https://longbridge.com/en/quote/RBGLY.US.md)
- [RKT.UK](https://longbridge.com/en/quote/RKT.UK.md)

## Related News & Research

- [Reckitt Benckiser Buys Back 140,000 Shares, Updates Voting Rights](https://longbridge.com/en/news/282144872.md)
- [Reckitt Expands Treasury Stock with New Share Buyback](https://longbridge.com/en/news/282315061.md)
- [Hill & Smith Discloses Share Sale by Group President Tim Tehan](https://longbridge.com/en/news/283026988.md)
- [Terrestrial Energy hires new employment pacts for CFO Brian Thrasher, COO William Smith and CTO David LeBlanc](https://longbridge.com/en/news/283052572.md)
- [09:17 ETCarShield Taps Stephen A. Smith as Bold New Voice for Drivers](https://longbridge.com/en/news/282699457.md)